Gender-based differences in pharmacokinetics in laboratory animal models

Area of Science:

• Pharmacology
• Toxicology
• Animal Science

Background:

• Gender-based differences in pharmacokinetics (PK) are increasingly recognized in animal studies.
• Early observations in 1932 noted gender-dependent responses to barbiturates in rats.
• Hepatic metabolism, particularly differences in cytochrome P450 enzyme expression, underlies many gender-related PK variations.

Purpose of the Study:

• To review and synthesize the literature on gender-based differences in compound pharmacokinetics across various animal species.
• To explore the factors influencing these PK differences and their impact on compound behavior.
• To discuss the implications of gender-dependent PK for toxicity and drug development in preclinical research.

Main Methods:

• Literature review of studies investigating gender-based differences in pharmacokinetics (PK).
• Analysis of factors controlling PK parameters like clearance (CL) and volume (V).
• Examination of examples illustrating gender-specific PK profiles and toxicity.

Main Results:

• Significant gender-dependent differences in PK parameters (CL and V) are observed across multiple species including rats, mice, rabbits, and cattle.
• Hepatic metabolism, driven by sex-specific enzyme expression (e.g., CYP450s), is a primary driver of these gender-related PK variations.
• Gender-based differences in PK contribute to observed gender differences in compound toxicity in nonclinical species.

Conclusions:

• Gender is a critical factor influencing compound pharmacokinetics and toxicity in animal models.
• Understanding these sex-specific differences is essential for accurate interpretation of preclinical data.
• Further research into gender-dependent PK can improve the safety and efficacy of drug development.